Publications
Detailed Information
Gene Transfer of TRPC6DN (Dominant Negative) Restores Erectile Function in Diabetic Rats
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Jung, Jae Hun | - |
dc.contributor.author | Kim, Byung Joo | - |
dc.contributor.author | Chae, Mee Ree | - |
dc.contributor.author | Kam, Sung Chul | - |
dc.contributor.author | So, Insuk | - |
dc.contributor.author | Lee, Sung Won | - |
dc.contributor.author | Chung, Ky Hyun | - |
dc.contributor.author | Jeon, Ju-Hong | - |
dc.date.accessioned | 2012-05-22T05:39:45Z | - |
dc.date.available | 2012-05-22T05:39:45Z | - |
dc.date.issued | 2010-03 | - |
dc.identifier.citation | JOURNAL OF SEXUAL MEDICINE; Vol.7 3; 1126-1138 | ko_KR |
dc.identifier.issn | 1743-6095 | - |
dc.identifier.uri | https://hdl.handle.net/10371/76230 | - |
dc.description.abstract | Introduction. Transient receptor potential (TRP) channels play an important role in modulating intracellular Ca2+ ([Ca2+](i) ) levels. Aim. We examined the hypothesis that overexpression of TRPC6DN (dominant negative) may contribute to decreased [Ca2+](i) levels in corporal smooth muscle (CSM). We also investigated whether gene transfer of TRPC6DN could restore erectile function in diabetic rats. Methods. For the in vitro study, the K(Ca), K(ATP), and TRPC6DN channel genes were transferred using cDNA, into cultured human CSM cells and human embryonic kidney cells. For the in vivo study, young adult rats were divided into three groups: normal controls; diabetic controls transfected with vector only; and a diabetic group transfected with pcDNA of the TRPC6DN gene. Main Outcome Measures. After gene transfer, the effects of reducing [Ca2+](i) levels were assessed by Fura-2-based imaging analysis. The intracavernosal pressure (ICP) response to cavernosal nerve stimulation was assessed after intracorporal injection of TRPC6DN pcDNA. The transgene expression of the TRPC6DN was examined by reverse transcription polymerase chain reaction (RT-PCR) in rats transfected with TRPC6DN pcDNA. Results. Gene transfer of ion channels effectively reduced [Ca2+](i) . Among these channels, transfer of the TRPC6DN gene resulted in the greatest reduction of [Ca2+](i) in human CSM. The mean (+/- standard error of the mean) ratio of ICP to mean arterial pressure (BP) in the gene-transfer rats was 79.4 +/- 2.4% (N = 8). This was significantly higher than that in control rats (55.6 +/- 3.7% [N = 8]), and similar to that in the young control rats (83 +/- 2.2% [N = 12]). The RT-PCR showed expression of TRPC6DN genes in the transfected rats. Conclusion. Gene transfer of TRPC6DN not only reduced [Ca2+](i) in human CSM but also restored erectile function in diabetic rats. These results suggest that pcDNA transfer of TRPC6DN may represent a promising new form of therapy for the treatment of male erectile dysfunction in the future. Jung JH, Kim BJ, Chae MR, Kam SC, Jeon J-H, So I, Chung KH, and Lee SW. Gene transfer of TRPC6DN (dominant negative) restores erectile function in diabetic rats. J Sex Med 2010;7:1126-1138. | ko_KR |
dc.language.iso | en | ko_KR |
dc.publisher | WILEY-BLACKWELL PUBLISHING, INC | ko_KR |
dc.subject | TRPC6DN Gene | ko_KR |
dc.subject | Erectile Function | ko_KR |
dc.subject | Gene Therapy | ko_KR |
dc.subject | Gene Transfer | ko_KR |
dc.title | Gene Transfer of TRPC6DN (Dominant Negative) Restores Erectile Function in Diabetic Rats | ko_KR |
dc.type | Article | ko_KR |
dc.contributor.AlternativeAuthor | 정재헌 | - |
dc.contributor.AlternativeAuthor | 김병주 | - |
dc.contributor.AlternativeAuthor | 채미리 | - |
dc.contributor.AlternativeAuthor | 감성철 | - |
dc.contributor.AlternativeAuthor | 전주홍 | - |
dc.contributor.AlternativeAuthor | 소인석 | - |
dc.contributor.AlternativeAuthor | 정기현 | - |
dc.contributor.AlternativeAuthor | 이성원 | - |
dc.identifier.doi | 10.1111/j.1743-6109.2009.01634.x | - |
dc.citation.journaltitle | JOURNAL OF SEXUAL MEDICINE | - |
dc.description.citedreference | Hu GQ, 2009, MOL ENDOCRINOL, V23, P689, DOI 10.1210/me.2008-0350 | - |
dc.description.citedreference | Xie DH, 2008, J SEX MED, V5, P2069, DOI 10.1111/j.1743-6109.2008.00933.x | - |
dc.description.citedreference | Lee M, 2008, J SEX MED, V5, P1355, DOI 10.1111/j.1743-6109.2008.00771.x | - |
dc.description.citedreference | Liu DY, 2008, ARTERIOSCL THROM VAS, V28, P746, DOI 10.1161/ATVBAHA.108.162222 | - |
dc.description.citedreference | Han DH, 2008, J SEX MED, V5, P822, DOI 10.1111/j.1743-6109.2007.00732.x | - |
dc.description.citedreference | Bivalacqua TJ, 2008, J SEX MED, V5, P268 | - |
dc.description.citedreference | So I, 2007, BJU INT, V100, P1154, DOI 10.1111/j.1464-410X.2007.07050.x | - |
dc.description.citedreference | DIETRICH A, 2007, HANDB EXP PHARM, V179, P125 | - |
dc.description.citedreference | Lau DHW, 2007, ASIAN J ANDROL, V9, P8, DOI 10.1111/j.1745-7262.2007.00224.x | - |
dc.description.citedreference | HAN DH, 2007, INT J IMPOT RES, V20, P53 | - |
dc.description.citedreference | So I, 2005, INT J IMPOT RES, V17, P475, DOI 10.1038/sj.ijir.3901356 | - |
dc.description.citedreference | Dietrich A, 2005, MOL CELL BIOL, V25, P6980, DOI 10.1128/MCB.25.16.6980-6989.2005 | - |
dc.description.citedreference | Christ GJ, 2004, AM J PHYSIOL-HEART C, V287, pH1544, DOI 10.1152/ajpheart.00792.2003 | - |
dc.description.citedreference | Bivalacqua TJ, 2004, P NATL ACAD SCI USA, V101, P9121, DOI 10.1073/pnas.0400520101 | - |
dc.description.citedreference | CHRIST GJ, 2004, CURR UROL REP, V5, P52 | - |
dc.description.citedreference | Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196 | - |
dc.description.citedreference | Insuk SO, 2003, INT J IMPOT RES, V15, P258, DOI 10.1038/sj.ijir.3901013 | - |
dc.description.citedreference | Bivalacqua TJ, 2003, J UROLOGY, V169, P1911, DOI 10.1097/01.ju.0000051881.14239.4a | - |
dc.description.citedreference | BIVALACQUA TJ, 2003, AM J PHYSIOL-HEART C, V284, P1408 | - |
dc.description.citedreference | Chitaley K, 2002, BIOCHEM BIOPH RES CO, V298, P427 | - |
dc.description.citedreference | MAGEE TR, 2002, SOC STUDY REPROD, V1, P20 | - |
dc.description.citedreference | Tirney S, 2001, MOL UROL, V5, P37 | - |
dc.description.citedreference | SCHENK G, 2001, CURR UROL REP, V2, P480 | - |
dc.description.citedreference | BIVALACQUA TJ, 2001, SOC STUDY REPROD, V1, P1371 | - |
dc.description.citedreference | INOUE R, 2001, AM HEART ASS, P325 | - |
dc.description.citedreference | Yla-Herttuala S, 2000, LANCET, V355, P213 | - |
dc.description.citedreference | Cellek S, 1999, BRIT J PHARMACOL, V128, P1804 | - |
dc.description.citedreference | Melman A, 1999, J UROLOGY, V161, P5 | - |
dc.description.citedreference | Christ GJ, 1998, AM J PHYSIOL-HEART C, V275, pH600 | - |
dc.description.citedreference | Boulay G, 1997, J BIOL CHEM, V272, P29672 | - |
dc.description.citedreference | Rehman J, 1997, AM J PHYSIOL-HEART C, V272, pH1960 | - |
dc.description.citedreference | BRINK PR, 1996, AM J PHYSIOL-CELL PH, V271, P321 | - |
dc.description.citedreference | CHANG MW, 1995, J CLIN INVEST, V96, P2260 | - |
dc.description.citedreference | ZHAO WX, 1995, J UROLOGY, V154, P1571 | - |
dc.description.citedreference | GARBAN H, 1995, AM J PHYSIOL, V268, P467 | - |
dc.description.citedreference | PALMER LS, 1994, J UROLOGY, V152, P1308 | - |
dc.description.citedreference | CARRIER S, 1993, UROLOGY, V42, P468 | - |
dc.description.citedreference | CHRIST GJ, 1993, INT J IMPOT RES, V5, P77 | - |
dc.description.tc | 2 | - |
- Appears in Collections:
- Files in This Item:
- There are no files associated with this item.
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.